Mohamed Ayan

Research Field

Valve replacement

Cite

Citations (0)

Acute myocardial infarction in a young man with large left ventricular thrombus and the antiphospholipid syndrome

Baylor University Medical Center Proceedings (2018)

Mohamed Ayan Yazeid Alshebani Hamza Tantoush Mohsin Salih Waiel Abusnina

Antiphospholipid syndrome is an autoimmune disorder that presents clinically with venous and/or arterial thrombosis and can affect any organ. Coronary artery involvement and left ventricular thrombus are rare presentations. We report the case of a 23-year-old male smoker with a strong family history of premature coronary artery disease who presented with acute anterolateral ST elevation myocardial infarction and large left ventricular thrombus. He was treated with primary percutaneous coronary intervention with thrombectomy without stenting. He was later diagnosed with antiphospholipid syndrome.

Left Ventricular Thrombus

10.1080/08998280.2018.1503479

Cite

Citations (2)

TCT-280 Impact of Diabetes Mellitus on Graft Patency following Coronary Artery Bypass Graft Surgery: a Propensity Score Analysis

Journal of the American College of Cardiology (2015)

Mohamed Ayan Alok Saurav Amjad Kabach Aiman Smer Mohsin Salih

Graft occlusion

Bypass surgery

10.1016/j.jacc.2015.08.294

Cite

Citations (5)

Hand ischemia after transradial coronary angiography: Resulting in right ring finger amputation

Cardiovascular revascularization medicine (2015)

Mohamed Ayan Aiman Smer Muhammad Soubhi Azzouz Ahmed Abu‐Zaid Aryan N. Mooss

10.1016/j.carrev.2015.06.002

Cite

Citations (17)

Subacute stent thrombosis in a patient with COVID-19 pneumonia

Baylor University Medical Center Proceedings (2020)

Mohamed Ayan Swathi Kovelamudi Malek Al‐Hawwas

Acute and subacute stent thromboses are rare but life-threatening complications of primary coronary intervention and stenting. We present a case of a patient with COVID-19 infection who presented with pneumonia, acute respiratory failure, and non–ST elevation myocardial infarction. Reperfusion was achieved with coronary angioplasty and drug-eluting stent placement, and the patient was started on aspirin and clopidogrel. However, 72 hours later, the patient experienced an episode of subacute stent thrombosis. This raises concerns about a possible association between stent thrombosis and increased thrombogenicity and platelet aggregability triggered by COVID-19 infection.

Coronary stent

Thrombogenicity

10.1080/08998280.2020.1812792

Cite

Citations (9)

Meta-analysis of Randomized Controlled Trials on Patent Foramen Ovale Closure Versus Medical Therapy for Secondary Prevention of Cryptogenic Stroke

The American Journal of Cardiology (2018)

Aiman Smer Mohsin Salih Toufik Mahfood Haddad Raviteja Guddeti Abdulghani Saadi

Stroke

Medical Therapy

10.1016/j.amjcard.2018.02.021

Cite

Citations (17)

Multiple admissions to the coronary care unit due to falsely elevated cardiac troponin

Baylor University Medical Center Proceedings (2018)

Mohamed Ayan Zaid Gheith Aneesha Ananthula Mohsin Salih Srikanth Vallurupalli

The measurement of cardiac troponin, released from injured cardiomyocytes, is of paramount importance in the diagnosis of acute myocardial infarction. Elevated troponin can be encountered, however, in patients with cardiomyopathy, significant cardiac arrhythmias, vasculitis, right-sided heart strain, critical systemic illnesses, stroke, drug toxicity (such as Adriamycin), poisons (such as snake venoms), renal failure, seizure, and rhabdomyolysis. If the clinical picture is not consistent with any of these causes, a false-positive result should be considered. We herein describe a 94-year-old man with a prior history of coronary artery disease who presented with altered mental status and was found to have a persistently high troponin level resulting in three admissions to the coronary care unit for various noncardiac complaints. Because of discordance between clinical and laboratory data, immunological interference due to heterophile antibodies in the locally used assay (AccuTnI+3, Beckman Coulter) was suspected. The same serum sample tested on a different assay (Elecsys Troponin I Assay, Roche) resulted in an undetectable cardiac troponin I level, thus confirming the diagnosis.

Coronary care unit

Heterophile

Cardiac marker

10.1080/08998280.2018.1440856

Cite

Citations (5)

COCAINE TOXICITY PRESENTING AS ACUTE REVERSIBLE PULMONARY HYPERTENSION AND RIGHT HEART FAILURE

Journal of the American College of Cardiology (2015)

Mahesh Anantha Narayanan Toufik Mahfood Haddad Aiman Smer Mohamed Ayan Aryan N. Mooss

Right heart failure

Pulmonary toxicity

10.1016/s0735-1097(15)60645-3